X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.
Dibbens LM., Tarpey PS., Hynes K., Bayly MA., Scheffer IE., Smith R., Bomar J., Sutton E., Vandeleur L., Shoubridge C., Edkins S., Turner SJ., Stevens C., O'Meara S., Tofts C., Barthorpe S., Buck G., Cole J., Halliday K., Jones D., Lee R., Madison M., Mironenko T., Varian J., West S., Widaa S., Wray P., Teague J., Dicks E., Butler A., Menzies A., Jenkinson A., Shepherd R., Gusella JF., Afawi Z., Mazarib A., Neufeld MY., Kivity S., Lev D., Lerman-Sagie T., Korczyn AD., Derry CP., Sutherland GR., Friend K., Shaw M., Corbett M., Kim H-G., Geschwind DH., Thomas P., Haan E., Ryan S., McKee S., Berkovic SF., Futreal PA., Stratton MR., Mulley JC., Gécz J.
Epilepsy and mental retardation limited to females (EFMR) is a disorder with an X-linked mode of inheritance and an unusual expression pattern. Disorders arising from mutations on the X chromosome are typically characterized by affected males and unaffected carrier females. In contrast, EFMR spares transmitting males and affects only carrier females. Aided by systematic resequencing of 737 X chromosome genes, we identified different protocadherin 19 (PCDH19) gene mutations in seven families with EFMR. Five mutations resulted in the introduction of a premature termination codon. Study of two of these demonstrated nonsense-mediated decay of PCDH19 mRNA. The two missense mutations were predicted to affect adhesiveness of PCDH19 through impaired calcium binding. PCDH19 is expressed in developing brains of human and mouse and is the first member of the cadherin superfamily to be directly implicated in epilepsy or mental retardation.